Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M van Griensven

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Clinical Pharmacokinetics|April 1, 1995
Drug interactions with thrombolytic agents. Current perspectivesA de Boer, J M van Griensven
Thrombosis and Haemostasis|March 1, 1995
On the role of C1-inhibitor as inhibitor of tissue-type plasminogen activator in human plasmaL G Huisman, J M van Griensven, C Kluft
British Journal of Clinical Pharmacology|July 1, 1993
A cross-over comparison of the anti-clotting effects of three low molecular weight heparins and glycosaminoglycuronanJ C Stiekema, J M Van Griensven, T G Van Dinther, et al.
European Journal of Clinical Pharmacology|January 1, 1993
The pharmacokinetic and pharmacodynamic interactions of ramipril with propranololJ M van Griensven, M Seibert-Grafe, H C Schoemaker, et al.
European Journal of Clinical Pharmacology|January 1, 1995
Pharmacokinetics, pharmacodynamics and bioavailability of the ACE inhibitor ramiprilJ M van Griensven, R C Schoemaker, A F Cohen, et al.
European Journal of Clinical Pharmacology|April 7, 1999
The oral bioavailability of pentosan polysulphate sodium in healthy volunteersR A Faaij, N Srivastava, J M van Griensven, et al.
Clinical Pharmacology and Therapeutics|November 1, 1996
Effects of increased liver blood flow on the kinetics and dynamics of recombinant tissue-type plasminogen activatorJ M van Griensven, L G Huisman, T Stuurman, et al.
Clinical Pharmacology and Therapeutics|December 1, 1995
Tolrestat pharmacokinetic and pharmacodynamic effects on red blood cell sorbitol levels in normal volunteers and in patients with insulin-dependent diabetesJ M van Griensven, W J Jusko, H H Lemkes, et al.
Thrombosis and Haemostasis|December 20, 1993
Effect of isotretinoin on endogenous tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) in humansA E Wallnöfer, J M van Griensven, H C Schoemaker, et al.
Psychopharmacology|July 8, 1999
The effect of m-CPP on tics and obsessive-compulsive phenomena in Gilles de la Tourette syndromeD C Cath, H J Gijsman, R C Schoemaker, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinical Pharmacokinetics|April 1, 1995
Drug interactions with thrombolytic agents. Current perspectivesA de Boer, J M van Griensven
Thrombosis and Haemostasis|March 1, 1995
On the role of C1-inhibitor as inhibitor of tissue-type plasminogen activator in human plasmaL G Huisman, J M van Griensven, C Kluft
British Journal of Clinical Pharmacology|July 1, 1993
A cross-over comparison of the anti-clotting effects of three low molecular weight heparins and glycosaminoglycuronanJ C Stiekema, J M Van Griensven, T G Van Dinther, et al.
European Journal of Clinical Pharmacology|January 1, 1993
The pharmacokinetic and pharmacodynamic interactions of ramipril with propranololJ M van Griensven, M Seibert-Grafe, H C Schoemaker, et al.
European Journal of Clinical Pharmacology|January 1, 1995
Pharmacokinetics, pharmacodynamics and bioavailability of the ACE inhibitor ramiprilJ M van Griensven, R C Schoemaker, A F Cohen, et al.
European Journal of Clinical Pharmacology|April 7, 1999
The oral bioavailability of pentosan polysulphate sodium in healthy volunteersR A Faaij, N Srivastava, J M van Griensven, et al.
Clinical Pharmacology and Therapeutics|November 1, 1996
Effects of increased liver blood flow on the kinetics and dynamics of recombinant tissue-type plasminogen activatorJ M van Griensven, L G Huisman, T Stuurman, et al.
Clinical Pharmacology and Therapeutics|December 1, 1995
Tolrestat pharmacokinetic and pharmacodynamic effects on red blood cell sorbitol levels in normal volunteers and in patients with insulin-dependent diabetesJ M van Griensven, W J Jusko, H H Lemkes, et al.
Thrombosis and Haemostasis|December 20, 1993
Effect of isotretinoin on endogenous tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) in humansA E Wallnöfer, J M van Griensven, H C Schoemaker, et al.
Psychopharmacology|July 8, 1999
The effect of m-CPP on tics and obsessive-compulsive phenomena in Gilles de la Tourette syndromeD C Cath, H J Gijsman, R C Schoemaker, et al.
Pageof 2